Clinical impact of a gastrointestinal PCR panel in children with infectious diarrhoea.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
06 2022
Historique:
received: 15 05 2021
accepted: 28 11 2021
pubmed: 19 12 2021
medline: 24 5 2022
entrez: 18 12 2021
Statut: ppublish

Résumé

Multiplex gastrointestinal PCR (GI-PCR) allows fast and simultaneous detection of 22 enteric pathogens (including All children eligible for stool culture from May to October 2018 were prospectively included in a monocentric study at Robert-Debré University-Hospital. A GI-PCR (BioFire FilmArray) was performed on each stool sample. Data on the children's healthcare management before and after GI-PCR results were collected. Stool culture results were also reported. 172 children were included. The main criteria for performing stool analysis were mucous/bloody diarrhoea and/or traveller's diarrhoea (n=130). GI-PCR's were positive for 120 patients (70%). The main pathogens were enteroaggregative The GI-PCR's results impacted the medical management of gastroenteritis for almostone-fourth of the children, and especially the prescription of appropriate antibiotic treatment before stool culture results.

Identifiants

pubmed: 34921002
pii: archdischild-2021-322465
doi: 10.1136/archdischild-2021-322465
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-605

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jeanne Truong (J)

General Paediatrics, Robert Debré University Hospital, AP-HP, Paris, France jeanne.truong09@gmail.com.
Université de Paris, UFR de médecine Paris-Nord, Paris, Île-de-France, France.

Aurélie Cointe (A)

Microbiology Laboratory, Robert-Debré University Hospital, AP-HP, Paris, Île-de-France, France.
IAME UMR 1137, INSERM, Paris, Île-de-France, France.

Enora Le Roux (E)

Unité d'Epidémiologie Clinique, Robert Debré University Hospital, AP-HP, Paris, France.
ECEVE UMR-1123, INSERM, Paris, Île-de-France, France.

Philippe Bidet (P)

Microbiology Laboratory, Robert-Debré University Hospital, AP-HP, Paris, Île-de-France, France.
IAME UMR 1137, INSERM, Paris, Île-de-France, France.

Morgane Michel (M)

ECEVE UMR-1123, INSERM, Paris, Île-de-France, France.
URC Eco, Hôtel-Dieu, AP-HP, Paris, France.

Julien Boize (J)

Department of Paediatric Emergency Care, Robert Debré University Hospital, AP-HP, Paris, Île-de-France, France.

Patricia Mariani-Kurkdjian (P)

Microbiology Laboratory, Robert-Debré University Hospital, AP-HP, Paris, Île-de-France, France.

Marion Caseris (M)

General Paediatrics, Robert Debré University Hospital, AP-HP, Paris, France.

Claire Amaris Hobson (CA)

Université de Paris, UFR de médecine Paris-Nord, Paris, Île-de-France, France.
IAME UMR 1137, INSERM, Paris, Île-de-France, France.

Marie Desmarest (M)

Department of Paediatric Emergency Care, Robert Debré University Hospital, AP-HP, Paris, Île-de-France, France.

Luigi Titomanlio (L)

Université de Paris, UFR de médecine Paris-Nord, Paris, Île-de-France, France.
Department of Paediatric Emergency Care, Robert Debré University Hospital, AP-HP, Paris, Île-de-France, France.
U1141, INSERM, Paris, France.

Albert Faye (A)

General Paediatrics, Robert Debré University Hospital, AP-HP, Paris, France.
Université de Paris, UFR de médecine Paris-Nord, Paris, Île-de-France, France.
ECEVE UMR-1123, INSERM, Paris, Île-de-France, France.

Stéphane Bonacorsi (S)

Microbiology Laboratory, Robert-Debré University Hospital, AP-HP, Paris, Île-de-France, France.
IAME UMR 1137, INSERM, Paris, Île-de-France, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH